Dymaxium has been awarded a new project with a major pharmaceutical company to design analysis and management tools for two diseases. The tools will be used by healthcare institutions to host and analyze their patient data, understand their current disease management, and learn the importance and compliance of treatment guidelines. This tool will analyze the data and compare sundry parameters of the two disease treatments with their counterparts in widely accepted guidelines to understand hospitals' current practice from clinical and economical perspective, further locate the shortfall of current disease management, and identify the opportunities to improve the quality of care. This tool also can save and load the input data for future comparison to assist healthcare institutions in evaluating their performance.

For more information on our products, please visit http://www.dymaxium.com/portfolio.